_PRIVATE_LIMITED.webp)
Zefe Labs (I) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 17 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.37 Cr
as on 24-10-2024
- Revenue -13.92%
(FY 2023)
- Profit -75.95%
(FY 2023)
- Ebitda -62.02%
(FY 2023)
- Net Worth 3.96%
(FY 2023)
- Total Assets -35.53%
(FY 2023)
About Zefe Labs (I)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.37 Cr.
Sukhwinder Toor, Gurmeet Toor, and Manjit Bhullar serve as directors at the Company.
- CIN/LLPIN
U74110MP2007PTC019484
- Company No.
019484
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Apr 2007
- Date of AGM
20 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Zefe Labs (I) Private Limited offer?
Zefe Labs (I) Private Limited offers a wide range of products and services, including Essential & Aromatic Oils, Carrier Oil, Ayurvedic Powder and Medicinal Herbs, Herbal Powder, Edible Oil & Allied Products, Cold Pressed Oil, Nutraceuticals & Dietary Supplements, Dietary Supplements, Bird Food, Poultry & Animal Food, Animal Feed.
Who are the key members and board of directors at Zefe Labs (I)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gurmeet Toor  | Whole-Time Director | 28-Nov-2009 | Current |
| Sukhwinder Toor | Whole-Time Director | 25-Apr-2007 | Current |
| Manjit Bhullar | Whole-Time Director | 28-Nov-2009 | Current |
Financial Performance of Zefe Labs (I).
Zefe Labs (I) Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 13.92% decrease. The company also saw a substantial fall in profitability, with a 75.95% decrease in profit. The company's net worth moved up by a moderate rise of 3.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zefe Labs (I)?
In 2023, Zefe Labs (I) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 25 May 2023 | ₹1.50 Cr | Open |
Others Creation Date: 19 Jan 2021 | ₹1.20 M | Open |
Others Creation Date: 28 May 2015 | ₹1.50 M | Open |
How Many Employees Work at Zefe Labs (I)?
Unlock and access historical data on people associated with Zefe Labs (I), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zefe Labs (I), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zefe Labs (I)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
